RAM
BPMC

Riggs Asset Management’s Blueprint Medicines BPMC Stock Holding History

Riggs Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22
Closed -$2.82K – 225
2025
Q2 		$2.82K Buy
22
+10
+83% +$1.04K ﹤0.01% 582
2025
Q1 		$1.06K Hold
12
– – ﹤0.01% 478
2024
Q4 		$1.04K Hold
12
– – ﹤0.01% 448
2024
Q3 		$1.11K Hold
12
– – ﹤0.01% 427
2024
Q2 		$1.29K Hold
12
– – ﹤0.01% 405
2024
Q1 		$1.14K Buy
+12
New +$1.03K ﹤0.01% 404

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Riggs Asset Management's BPMC Position: Q3 2025 in Review

Riggs Asset Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 22 shares — an estimated $2.82K sold.

Riggs Asset Management first reported a position in BPMC in Q1 2024 and held it in 6 quarters. The position peaked at $2.82K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Riggs Asset Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 22 Blueprint Medicines shares in Q3 2025, an estimated $2.82K.
  • Riggs Asset Management first reported a position in Blueprint Medicines in Q1 2024 and held it in 6 quarters.
  • Riggs Asset Management's Blueprint Medicines position peaked at $2.82K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.